The present value of human life losses associated with COVID-19 and likely productivity losses averted through COVID-19 vaccination in Madagascar
View abstract on PubMed
Summary
This summary is machine-generated.Madagascar
Area Of Science
- Public Health
- Health Economics
- Epidemiology
Background
- Madagascar reported 1,422 COVID-19 deaths by March 3, 2023.
- No prior studies estimated the Total Present Value of Human Life lost (TPVHL) or productivity losses in Madagascar due to COVID-19.
Purpose Of The Study
- To estimate the TPVHL and productivity losses from COVID-19 deaths in Madagascar.
- To quantify potential productivity gains from COVID-19 vaccination for advocacy.
Main Methods
- Utilized the Human Capital Model (HCM) to calculate TPVHL across seven age groups.
- Calculated Present Value of Human Life (PVHL) using discount factors, life expectancy, GDP per capita, and COVID-19 mortality.
- Performed sensitivity analyses with varying discount rates, life expectancies, excess mortality projections, and vaccine coverage levels.
Main Results
- The 1,422 COVID-19 deaths represented a TPVHL of Int$46,331,412 (average Int$32,582 per life).
- Sensitivity analyses showed significant impact of discount rates and life expectancy on TPVHL.
- Projected excess mortality substantially increased TPVHL, while 70% vaccine coverage could save Int$1.1 billion (1.94% of GDP).
Conclusions
- COVID-19 has caused substantial health and economic losses in Madagascar.
- Optimizing COVID-19 vaccination coverage is crucial for mitigating these losses.

